Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases. Gulsin GS, Graham-Brown MPM, Squire IB, Davies MJ, et al. Heart 2022;108:16-21.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gulsin GS, Graham-Brown MPM, Squire IB, Davies MJ, et al. Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases. Heart 2022;108:16-21.
PMID: 33972360